Abstract
various molecules present in the type I IFN signaling pathway. The oral administration of Epimedium Koreanum Nakai exhibited both preventive and therapeutic effects on BALB/c mice against lethal doses of highly pathogenic influenza A subtypes containing H1N1, H5N2, H7N3 and H9N2. Conclusion: Our results clearly indicated that Epimedium Koreanum Nakai contains components that play roles as immunomodulators and may be potential candidates for new antiviral drugs. Contact: Won-Kyung Cho, wkcho@kiom.re.kr
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
